title: Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging.
abstract: Renal aging is characterized by structural changes in the kidney including fibrosis, which contributes to the increased risk of kidney and cardiac failure in the elderly. Studies involving healthy kidney donors demonstrated subclinical age-related nephropathy on renal biopsy that was not detected by standard diagnostic tests. Thus there is a high-priority need for novel noninvasive biomarkers to detect the presence of preclinical age-associated renal structural and functional changes. C-type natriuretic peptide (CNP) possesses renoprotective properties and is present in the kidney; however, its modulation during aging remains undefined. We assessed circulating and urinary CNP in a Fischer rat model of experimental aging and also determined renal structural and functional adaptations to the aging process. Histological and electron microscopic analysis demonstrated significant renal fibrosis, glomerular basement membrane thickening, and mesangial matrix expansion with aging. While plasma CNP levels progressively declined with aging, urinary CNP excretion increased, along with the ratio of urinary to plasma CNP, which preceded significant elevations in proteinuria and blood pressure. Also, CNP immunoreactivity was increased in the distal and proximal tubules in both the aging rat and aging human kidneys. Our findings provide evidence that urinary CNP and its ratio to plasma CNP may represent a novel biomarker for early age-mediated renal structural alterations, particularly fibrosis. Thus urinary CNP could potentially aid in identifying subjects with preclinical structural changes before the onset of symptoms and disease, allowing for the initiation of strategies designed to prevent the progression of chronic kidney disease particularly in the aging population.
authors.affiliation: Cardiorenal Research Laboratory, Div. of Cardiovascular Diseases, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA. sangaralingham.jeson@mayo.edu
authors.forename: S Jeson
authors.initials: SJ
authors.lastname: Sangaralingham
authors.forename: Denise M
authors.initials: DM
authors.lastname: Heublein
authors.forename: Joseph P
authors.initials: JP
authors.lastname: Grande
authors.forename: Alessandro
authors.initials: A
authors.lastname: Cataliotti
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Rule
authors.forename: Paul M
authors.initials: PM
authors.lastname: McKie
authors.forename: Fernando L
authors.initials: FL
authors.lastname: Martin
authors.forename: John C
authors.initials: JC
authors.lastname: Burnett
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D000886:Anthropometry; D001485:Basement Membrane / Q000473:pathology; D015415:Biomarkers; D001706:Biopsy; D001794:Blood Pressure / Q000502:physiology; D001835:Body Weight / Q000502:physiology; D005355:Fibrosis; D060730:Glomerular Filtration Barrier; D007150:Immunohistochemistry; D007668:Kidney / Q000473:pathology; D007672:Kidney Cortex / Q000378:metabolism; D007674:Kidney Diseases / Q000473:pathology / Q000652:urine*; D007677:Kidney Function Tests; D007679:Kidney Medulla / Q000378:metabolism; D008297:Male; D046529:Microscopy, Electron, Transmission; D020098:Natriuretic Peptide, C-Type / Q000652:urine*; D009929:Organ Size / Q000502:physiology; D011507:Proteinuria / Q000652:urine; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D015415:Biomarkers; D020098:Natriuretic Peptide, C-Type